Search results for

The US government has become the first patent owner to license its rights to HIV/AIDS drugs to UNITAID in a boost to the organisation’s medicines patent pool

Lord Justice Jacob believes the current proposals for a European patent court will fail, but that reform will soon come through a “coalition of the willing”. In-house counsel can’t wait

Ella Cheong Spruson & Ferguson successfully represented a client in the inaugural revocation proceedings of two patents in Singapore. Kristian Robinson and Soo Ee Lin explain how their firm did it

The Russian companies Russky Standart Vodka, LVZ Topaz and Sibirsky LVZ produce vodka and are competitors in the market. Topaz and Sibirsky produce and sell vodkas like Green Mark Traditional Recipe, Green Mark Rye and others. The neck of every bottle of those brands carries a collar reading "Vodka No 1 in Russia". It is obviously implied that Topaz and Sibirsky produce the best quality vodkas on the Russian market. The Russian Antimonopoly Service is a watchdog for incorrect marketing practices and directed its attention to that statement.

Axel Verhauwen and Michael Bergermann of Krieger Mes & Graf v der Groeben explain the advantages that Germany’s specialist courts offer patent litigants

Mark Horsburgh and Paul Davis of Fisher Adams Kelly describe how the law can put designers in a very tricky situation if ownership is not agreed at the start of a contract

In a tough business environment, businesses need support for R&D. Mark Pullen of Watermark considers the value of government funded programmes available in Australia

Bart van Wezenbeek of Vereenigde considers the progression of patentability of chemical compounds leading to patent protection for naturally occurring substances

The market for foods for specific health uses in Japan is large and growing. Hiroshi Sorimachi of Kyowa Patent and Law Office explains how to obtain patent protection for functional foods

Grant Shoebridge and Jacinta Flattery-O’Brien of Shelston IP review the issues raised by a parliamentary inquiry into gene patents